[{"address1": "Tower 11", "address2": "Level 10, Avenue 5, No. 8 Jalan Kerinchi", "city": "Kuala Lumpur", "zip": "59200", "country": "Malaysia", "phone": "60 9 08517 7330", "website": "https://www.cyclacel.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, epigenetics, and mitosis biology in the United States and the United Kingdom. Its lead product, Plogosertib or plogo, is a PLK1 inhibitor, in solid tumors and hematological malignancies, which is in Phase 1/2 clinical trial. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Sing Ee Wong", "age": 43, "title": "Chairman, CEO & President", "yearBorn": 1981, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Cu Seng Kiu", "age": 34, "title": "Executive Director, CFO & Secretary", "yearBorn": 1990, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Gill  Christie", "age": 67, "title": "Director of Human Resources", "yearBorn": 1957, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Grace  Kim", "title": "Investor Relations Executive", "exercisedValue": 0, "unexercisedValue": 0}], "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.3181, "open": 0.3095, "dayLow": 0.3003, "dayHigh": 0.347, "regularMarketPreviousClose": 0.3181, "regularMarketOpen": 0.3095, "regularMarketDayLow": 0.3003, "regularMarketDayHigh": 0.347, "payoutRatio": 0.0, "beta": 0.528, "forwardPE": -0.16120604, "volume": 581882, "regularMarketVolume": 581882, "averageVolume": 2553416, "averageVolume10days": 14241290, "averageDailyVolume10Day": 14241290, "bid": 0.0, "ask": 0.338, "bidSize": 0, "askSize": 1, "marketCap": 66513392, "fiftyTwoWeekLow": 0.17, "fiftyTwoWeekHigh": 3.08, "priceToSalesTrailing12Months": 1546.8231, "fiftyDayAverage": 0.2792, "twoHundredDayAverage": 0.6339, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 62816704, "profitMargins": 0.0, "floatShares": 12456770, "sharesOutstanding": 207336000, "sharesShort": 27619, "sharesShortPriorMonth": 53583, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.0001, "heldPercentInsiders": 0.54647, "heldPercentInstitutions": 0.00205, "shortRatio": 0.16, "shortPercentOfFloat": 0.0022, "impliedSharesOutstanding": 207336000, "bookValue": -0.245, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -11212000, "trailingEps": -2.09, "forwardEps": -1.99, "lastSplitFactor": "1:15", "lastSplitDate": 1702857600, "enterpriseToRevenue": 1460.854, "enterpriseToEbitda": -5.236, "52WeekChange": -0.8614719, "SandP52WeekChange": 0.08001411, "lastDividendValue": 0.15, "lastDividendDate": 1745884800, "quoteType": "EQUITY", "currentPrice": 0.3208, "recommendationKey": "none", "totalCash": 3137000, "totalCashPerShare": 0.015, "ebitda": -11998000, "totalDebt": 0, "quickRatio": 0.5, "currentRatio": 0.586, "totalRevenue": 43000, "revenuePerShare": 0.008, "returnOnAssets": -1.16327, "grossProfits": 43000, "freeCashflow": -5268500, "operatingCashflow": -7990000, "revenueGrowth": -1.0, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -279.16278, "financialCurrency": "USD", "symbol": "CYCC", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "longName": "Cyclacel Pharmaceuticals, Inc.", "shortName": "Cyclacel Pharmaceuticals, Inc.", "exchange": "NCM", "messageBoardId": "finmb_125004", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "REGULAR", "regularMarketChangePercent": 0.84879, "regularMarketPrice": 0.3208, "corporateActions": [], "regularMarketTime": 1746724301, "fiftyDayAverageChange": 0.04160002, "fiftyDayAverageChangePercent": 0.1489972, "twoHundredDayAverageChange": -0.31309998, "twoHundredDayAverageChangePercent": -0.49392647, "priceToBook": -1.3093878, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1079447400000, "regularMarketChange": 0.002700001, "regularMarketDayRange": "0.3003 - 0.347", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 2553416, "fiftyTwoWeekLowChange": 0.1508, "fiftyTwoWeekLowChangePercent": 0.88705885, "fiftyTwoWeekRange": "0.17 - 3.08", "fiftyTwoWeekHighChange": -2.7591999, "fiftyTwoWeekHighChangePercent": -0.89584416, "fiftyTwoWeekChangePercent": -86.14719, "dividendDate": 1746057600, "earningsTimestamp": 1743624300, "earningsTimestampStart": 1747047540, "earningsTimestampEnd": 1747396800, "earningsCallTimestampStart": 1723667400, "earningsCallTimestampEnd": 1723667400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.09, "epsForward": -1.99, "displayName": "Cyclacel Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-05-08"}]